169 related articles for article (PubMed ID: 9109441)
1. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
Sevransky JE; Shaked G; Novogrodsky A; Levitzki A; Gazit A; Hoffman A; Elin RJ; Quezado ZM; Freeman BD; Eichacker PQ; Danner RL; Banks SM; Bacher J; Thomas ML; Natanson C
J Clin Invest; 1997 Apr; 99(8):1966-73. PubMed ID: 9109441
[TBL] [Abstract][Full Text] [Related]
2. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
Dugo L; Chatterjee PK; Mazzon E; McDonald MC; Paola RD; Fulia F; Caputi AP; Thiemermann C; Cuzzocrea S
Intensive Care Med; 2002 Jun; 28(6):775-88. PubMed ID: 12107686
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
[TBL] [Abstract][Full Text] [Related]
4. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels.
Kumar A; Haery C; Paladugu B; Kumar A; Symeoneides S; Taiberg L; Osman J; Trenholme G; Opal SM; Goldfarb R; Parrillo JE
J Infect Dis; 2006 Jan; 193(2):251-8. PubMed ID: 16362889
[TBL] [Abstract][Full Text] [Related]
5. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock.
Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH
Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746
[TBL] [Abstract][Full Text] [Related]
6. [Effects of extracellular signal-regulated kinase inhibition by AG126 on tissue tumor necrosis factor-alpha expression and multiple organ dysfunction in rats with postburn Staphylococcus aureus sepsis].
Yao YM; Cheng MH; Yao S; Liang HP; Li HY; Dong N; Yu Y; Sheng ZY
Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):391-5. PubMed ID: 15144664
[TBL] [Abstract][Full Text] [Related]
7. Increasing doses of pentoxifylline as a continuous infusion in canine septic shock.
Quezado ZM; Hoffman WD; Banks SM; Danner RL; Eichacker PQ; Susla GM; Natanson C
J Pharmacol Exp Ther; 1999 Jan; 288(1):107-13. PubMed ID: 9862760
[TBL] [Abstract][Full Text] [Related]
8. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock.
Freeman BD; Yatsiv I; Natanson C; Solomon MA; Quezado ZM; Danner RL; Banks SM; Hoffman WD
J Am Coll Surg; 1995 Mar; 180(3):286-92. PubMed ID: 7874338
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of tyrosine kinase inhibitors on mineralization of normal and tumor bone cells.
Klein BY; Tepper SH; Gal I; Shlomai Z; Ben-Bassat H
J Cell Biochem; 1997 Jun; 65(3):420-9. PubMed ID: 9138097
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tyrosine-kinase-mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis.
Balachandra S; Genovese T; Mazzon E; Di Paola R; Thiemerman C; Siriwardena AK; Cuzzocrea S
Surgery; 2005 Nov; 138(5):913-23. PubMed ID: 16291393
[TBL] [Abstract][Full Text] [Related]
11. The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditis.
George J; Barshack I; Goldberg I; Keren P; Gazit A; Levitzki A; Keren G; Roth A
Exp Mol Pathol; 2004 Jun; 76(3):234-41. PubMed ID: 15126106
[TBL] [Abstract][Full Text] [Related]
12. Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation.
Dimitrova P; Ivanovska N
Int Immunopharmacol; 2008 Nov; 8(11):1567-77. PubMed ID: 18656556
[TBL] [Abstract][Full Text] [Related]
13. The effect of tyrphostin AG-556 on intimal thickening in a mouse model of arterial injury.
George J; Barshack I; Keren P; Gazit A; Levitzki A; Keren G; Roth A
Exp Mol Pathol; 2005 Jun; 78(3):233-8. PubMed ID: 15924877
[TBL] [Abstract][Full Text] [Related]
14. The study of fecal-Escherichia coli peritonitis-induced septic shock in a neonatal pig model.
Dobkin ED; Lobe TE; Bhatia J; Oldham KT; Traber DL
Circ Shock; 1985; 16(4):325-36. PubMed ID: 3915235
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.
Quezado ZM; Natanson C; Banks SM; Alling DW; Koev CA; Danner RL; Elin RJ; Hosseini JM; Parker TS; Levine DM
J Pharmacol Exp Ther; 1995 Feb; 272(2):604-11. PubMed ID: 7853173
[TBL] [Abstract][Full Text] [Related]
16. Effects of the tyrosine kinase inhibitor tyrphostin AG 556 on acute necrotising pancreatitis in rats.
Alhan E; Cicek R; Erçin C; Orem A; Vanizor B; Cinel A
Eur J Surg; 2002; 168(10):557-62. PubMed ID: 12666696
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of topoisomerase I activity by tyrphostin derivatives, protein tyrosine kinase blockers: mechanism of action.
Aflalo E; Iftach S; Segal S; Gazit A; Priel E
Cancer Res; 1994 Oct; 54(19):5138-42. PubMed ID: 7923131
[TBL] [Abstract][Full Text] [Related]
18. Late administration of a lipophilic tyrosine kinase inhibitor prevents lipopolysaccharide and Escherichia coli-induced lethal toxicity.
Vanichkin A; Patya M; Gazit A; Levitzki A; Novogrodsky A
J Infect Dis; 1996 Apr; 173(4):927-33. PubMed ID: 8603973
[TBL] [Abstract][Full Text] [Related]
19. Effects of coenzyme Q10 on the mediator cascade of sepsis.
Lelli JL; Drongowski RA; Gastman B; Remick DG; Coran AG
Circ Shock; 1993 Mar; 39(3):178-87. PubMed ID: 8453741
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
